MXPA01010404A - Peptidos moduladores de adhesion y metodos para utilizarlos. - Google Patents

Peptidos moduladores de adhesion y metodos para utilizarlos.

Info

Publication number
MXPA01010404A
MXPA01010404A MXPA01010404A MXPA01010404A MXPA01010404A MX PA01010404 A MXPA01010404 A MX PA01010404A MX PA01010404 A MXPA01010404 A MX PA01010404A MX PA01010404 A MXPA01010404 A MX PA01010404A MX PA01010404 A MXPA01010404 A MX PA01010404A
Authority
MX
Mexico
Prior art keywords
methods
modulatory peptides
adhesion modulatory
adhesion
peptides
Prior art date
Application number
MXPA01010404A
Other languages
English (en)
Inventor
Samy Ashkar
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of MXPA01010404A publication Critical patent/MXPA01010404A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
MXPA01010404A 1999-04-16 2000-04-17 Peptidos moduladores de adhesion y metodos para utilizarlos. MXPA01010404A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12970999P 1999-04-16 1999-04-16
PCT/US2000/010329 WO2000063236A2 (en) 1999-04-16 2000-04-17 Adhesion modulatory peptides and methods for use

Publications (1)

Publication Number Publication Date
MXPA01010404A true MXPA01010404A (es) 2003-07-21

Family

ID=22441219

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01010404A MXPA01010404A (es) 1999-04-16 2000-04-17 Peptidos moduladores de adhesion y metodos para utilizarlos.

Country Status (9)

Country Link
US (1) US20020058336A1 (es)
EP (1) EP1173469A2 (es)
JP (1) JP2003502019A (es)
AU (1) AU777844B2 (es)
BR (1) BR0009804A (es)
CA (1) CA2365949A1 (es)
IL (1) IL145850A0 (es)
MX (1) MXPA01010404A (es)
WO (1) WO2000063236A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60131525T2 (de) 2000-03-23 2008-09-25 Glaxo Group Ltd., Greenford Verfahren zum screening von inhibitoren für osteopontin
WO2003030925A1 (en) * 2001-10-02 2003-04-17 Kiyoshi Nokihara Angiogenesis drugs
AU2003276828A1 (en) * 2002-05-10 2004-03-11 Children's Medical Center Corporation Minicell display and products therefrom
US7678889B2 (en) 2002-08-06 2010-03-16 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
EP1610752B1 (en) 2003-01-31 2013-01-02 Boston Scientific Limited Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same
WO2004098627A1 (en) * 2003-05-06 2004-11-18 Royal College Of Surgeons In Ireland Inhibition of platelet aggregation through acyclovir and two peptide antagonists
US20080050812A1 (en) * 2003-05-30 2008-02-28 Cox James W Micropositioning Cells For Tissue Engineering
WO2005068504A1 (ja) * 2004-01-19 2005-07-28 Medical And Biological Laboratories Co., Ltd. 炎症性サイトカイン抑制剤
US20050220760A1 (en) * 2004-04-02 2005-10-06 Clemson University Novel immunotherapy
US20070048383A1 (en) * 2005-08-25 2007-03-01 Helmus Michael N Self-assembled endovascular structures
EP2010276B1 (en) * 2006-04-26 2014-01-22 Covidien LP Multi-stage microporation device
FR2915394B1 (fr) * 2007-04-27 2012-12-14 Vincience Composition pharmaceutique et/ou cosmetique contenant des peptides
FR2915393B1 (fr) 2007-04-27 2012-12-14 Vincience Composition pharmaceutique et/ou cosmetique contenant un principe actif activateur du cytochrome c
JP5664992B2 (ja) * 2009-08-26 2015-02-04 国立大学法人名古屋大学 細胞特異的ペプチド及びその用途
ES2575160T3 (es) * 2010-03-15 2016-06-24 The Board Of Trustees Of The University Of Illinois Inhibidores de las interacciones que unen la subunidad alfa de la beta integrina-proteína G
JP5792442B2 (ja) * 2010-09-01 2015-10-14 帝人株式会社 細胞特異的ペプチドを含有する繊維構造体
CA2866618A1 (en) * 2012-03-09 2013-09-12 Massachusetts Institute Of Technology Adhesion signatures
WO2015120536A1 (en) * 2014-02-13 2015-08-20 Arch Cancer Therapeutics, Inc. Peptides that block leukocyte recruitment and methods of use
JP6994193B2 (ja) * 2016-09-09 2022-01-14 国立研究開発法人国立循環器病研究センター 生分解性オリゴマー、親水性セグメント、及び細胞接着性ペプチドから成る化合物及びその利用
IT202100023357A1 (it) * 2021-09-09 2023-03-09 Cheirontech S R L Peptidi con attività anti-angiogenica

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85372A (en) * 1987-02-12 1992-12-01 Us Health Penta to nona-peptides with laminin - like activity having an amino acid sequence and anti- metastatic compositions containing them
US4870160A (en) * 1987-08-19 1989-09-26 Regents Of The University Of Minnesota Polypeptides with laminin activity
AU639409B2 (en) * 1987-12-10 1993-07-29 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5330900A (en) * 1987-12-31 1994-07-19 Tropix, Inc. Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes
US5049659A (en) * 1988-02-09 1991-09-17 Dana Farber Cancer Institute Proteins which induce immunological effector cell activation and chemattraction
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides
FR2665703B1 (fr) * 1990-08-10 1994-01-21 Roussel Uclaf Nouvelles microproteines, procede de preparation et application a titre de medicaments de ces nouvelles microproteines.
DE69115917T2 (de) * 1990-09-27 1996-05-23 Schering Corp Humane gammainterferonantagonisten
US5773574A (en) * 1990-12-03 1998-06-30 The Scripps Research Institute Polypeptides for promoting cell attachment
US5491130A (en) * 1992-11-10 1996-02-13 The United States Of America As Represented By The Department Of Health And Human Services Peptide inhibitors of fibronectin and related collagen-binding proteins
WO1994013692A1 (en) * 1992-12-10 1994-06-23 Regents Of The University Of Minnesota Polypeptides useful for treating inflammatory disorders
AU4815397A (en) * 1996-10-15 1998-05-11 Vanderbilt University Method of disrupting cellular adhesion
US6509026B1 (en) * 1997-08-15 2003-01-21 Children's Medical Center Corporation Osteopontin coated surfaces and methods of use
CA2370301A1 (en) * 1999-04-15 2000-10-26 Children's Medical Center Corporation Osteopontin-derived chemotactic and inhibitory agents and uses therefor

Also Published As

Publication number Publication date
IL145850A0 (en) 2002-07-25
WO2000063236A3 (en) 2001-06-28
CA2365949A1 (en) 2000-10-26
AU4356800A (en) 2000-11-02
AU777844B2 (en) 2004-11-04
WO2000063236A2 (en) 2000-10-26
US20020058336A1 (en) 2002-05-16
BR0009804A (pt) 2002-04-16
JP2003502019A (ja) 2003-01-21
EP1173469A2 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
AU7358700A (en) Dolastatin peptides
MXPA01010404A (es) Peptidos moduladores de adhesion y metodos para utilizarlos.
AU4806100A (en) P element derived vector and methods for its use
AU6758800A (en) Pump systems and methods
AU2001268459A1 (en) Secure test and test result delivery system
AU1951201A (en) Peptide antigens
AU6173900A (en) Peptide transport
GB9912852D0 (en) Peptides
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU6232300A (en) Receptors and associated proteins
AU2841801A (en) Triazolotriazinones and the use thereof
AU7795500A (en) Peptides which stimulate the immune response and tissue regeneration
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
MXPA02003270A (es) Peptido antigenico del virus de hepatitis e y metodos de elaboracion.
AU1083501A (en) Antibiotic-metal complex and methods
GB9918155D0 (en) Proteins and peptides
EP1173874A4 (en) PLASMA CANNON AND METHODS OF USE
AUPQ180499A0 (en) Beta-amyloid peptide inhibitors
EP1147130A4 (en) ALPHA-CONOTOXIN PEPTIDES
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
AU3473800A (en) Conotoxin peptides
GB9904695D0 (en) Peptide
AU2136401A (en) P450rai-2 and related proteins
IL144376A0 (en) Peptides
GB9908920D0 (en) Peptide